ࡱ> i RbjbjڲڲAP؏\؏\-#!}}8,M,***+++++++$ /16>+**"*"**>+}},****}}8+**+***pt)**+,0M,*1*1*1*,********>+>+****M,****1*********I C: DN Sf[N6RoSk6RBRvU_,{kQASNyb ^SoT(u Tye Tĉy*gۏSSxoTe,g N^81-4YfGrDotinurad Tablets/URECE0.5mg*h_O>y[XT*gۏSSxoTe,g N^81-5YfGrDotinurad Tablets/URECE1mg*h_O>y[XT*gۏSSxoTe,g N^81-6YfGrDotinurad Tablets/URECE2mg*h_O>y[XT*gۏSSxoTe,g N^81-7̖N4GrEstradiol transdermal system/Climara0.025mg/24hBayer HealthCare Pharmaceuticals, Inc.*gۏSSxoTVYjvfN81-8̖N4GrEstradiol transdermal system/Climara0.05mg/24hBayer HealthCare Pharmaceuticals, Inc.*gۏSSxoTVYjvfN81-9̖N4GrEstradiol transdermal system/Climara0.1mg/24hBayer HealthCare Pharmaceuticals, Inc.*gۏSSxoTVYjvfN81-10^tON@lOb^GrI Rosuvastatin Calcium and Ezetimibe Tablets (I)kGr+T^tON@l10mg c^tON@l NOb^10mgSanofi-Aventis Ireland Limited T/A SANOFIVQ N^vSxoTSxۏS81-11y*gۏSSxoTe,g N^81-44xxs|]gGrMirogabalin Besilate Tablets/ Tarlige2.5mgNC12H19NO2 ,{N NqQ*h_O>y*gۏSSxoTe,g N^30-111kbe@lST)]GrBilastine Orally disintegrating Tablets/Opexa; Bilaxten; Antires; Bitosen10mgMenarini International Operations/Faes Farma/Menarini International Operations Luxembourg S.A./Faes Farma, S.A.*gۏSSxoTXR N^Sc gNMenarini International Operations Luxembourg S.A./Faes Farma, S.A.23-280vx(ln"}GrAmbroxol Hydrochloride Tablets/Mucosolvan0Surbronc30mgSanofi-Aventis France/Boehringer Ingelheim France/OPELLA HEALTHCARE FRANCE SAS*gۏSSxoTXR N^Sc gNOPELLA HEALTHCARE FRANCE SAS6-27vx_VMexiletine Hydrochloride Capsules/Mexitil 50mgNippon Boehringer Ingelheim Co., Ltd./*Y}0000*h_O>ye,gYjvfNXR N^Sc gN*Y}0000*h_O>y6-28vx_VMexiletine Hydrochloride Capsules/Mexitil0.1gNippon Boehringer Ingelheim Co., Ltd./*Y}0000*h_O>ye,gYjvfNXR N^Sc gN*Y}0000*h_O>y55-34xxGrCalcium Carbonate Tablets/Caltan500mg0000*h_O>y/000000*h_O>y*gۏSSxoTXRSfT N^Sc gN000000*h_O>y65-29ZYNpn J ~ йййййййzzzt hAdCJhAdCJH*PJhAdCJPJhAdB*CJPJo(phhAdB*CJPJphhAdCJPJo(hAd hAdCJo(-hAdB*CJKHOJPJQJ\^Jo(ph)hAdB*CJOJPJQJ\^Jo(phhAdCJ,PJaJ,o(hAdCJ OJPJQJaJ o(+.06@FNT\dn $d$Ifa$$G$a$ npzMA333$d$9DIfa$ $d$Ifa$kd$$IfT44֞ 'v'c-^4r344 laf4T ( 2 4 > L A5 $d$Ifa$kd$$IfT4S֞ 'v'c-^4r344 laf4T$d$9DIfa$L Akd$$IfT4T֞ 'v'c-^4|r344 laf4T$d$9DIfa$~ L N V X l n p ~    P R X Z j l z |  ߾߾߾뾸hAdCJOJPJQJ^Jo(hAdCJPJo( hAdCJ hAdCJo(hAdB*CJPJo(phhAdB*CJPJphhAdB*CJPJphhAdCJPJhAdB*CJPJph? N X p $d$9DIfa$ $d$Ifa$ OC5555$d$9DIfa$ $d$Ifa$kdq$$IfT4.֞ 'v'c-^4|r344 laf4T  " R A5 $d$Ifa$kdE$$IfT4֞ 'v'c-^4|r344 laf4T$d$9DIfa$R Z l | A5 $d$Ifa$kd$$IfT4֞ 'v'c-^4|r344 laf4T$d$9DIfa$   Akd$$IfT4p֞ 'v'c-^4|r344 laf4T$d$9DIfa$   b d z | F H \ ^ (*<>.0BJfnp  ظظ̯į"hAdB*CJOJQJ^Jo(phhAdCJPJo(hAdB*CJPJphhAdCJPJhAdB*CJPJphhAdB*CJPJphhAdB*CJPJo(ph hAdCJ hAdCJo(>   d | $d$9DIfa$ $d$Ifa$ H ^ OC5555$d$9DIfa$ $d$Ifa$kd$$IfT4.֞ 'v'c-^4|r344 laf4T *A555 $d$Ifa$kd$$IfT4f֞ 'v'c-^4|r344 laf4T$d$9DIfa$*>Ckdi$$IfT47֞ 'v'c-^4|r344 laf4T $d$Ifa$0pCkdY$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$Ckde $$IfT4y֞ 'v'c-^4|r344 laf4T $d$Ifa$   $&((*BDF*,48BDVX *,>ѲѲĩhAdCJPJo("hAdB*CJOJQJ^Jo(ph hAdCJ hAdCJo(hAdB*CJPJo(phhAdCJPJhAdB*CJPJphhAdB*CJPJphB * $d$Ifa$*H,OCCCCCC $d$Ifa$kdq $$IfT4֞ 'v'c-^4|r344 laf4T,68DXCkdo $$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$ ,@Ckd{ $$IfT4S֞ 'v'c-^4|r344 laf4T $d$Ifa$&Ckd $$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$$HRT,68Vdfpt~ $.0B @NPX\fhthAdCJPJo( hAdCJ hAdCJo(hAdCJPJhAdB*CJPJphhAdB*CJPJo(phOCkd$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$HTCkdu$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$,8CkdW$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$Vfr $d$Ifa$rtOCCCCCC $d$Ifa$kd9$$IfT4֞ 'v'c-^4|r344 laf4T"$0DCkd$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$t~Ckd$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$~Ckd$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$@PZ\hvCkd$$IfT4.֞ 'v'c-^4|r344 laf4T $d$Ifa$vCkd$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$*rz| 0zjt    * , > !!R!T!^!`!!!!!!!hAdCJPJhAdCJPJo( hAdCJ hAdCJo(hAdB*CJPJo(phhAdB*CJPJphN,r|Ckd$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$ $d$Ifa$ 2zOCCCCCC $d$Ifa$kdg$$IfT4f֞ 'v'c-^4|r344 laf4Tjv CkdI$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$   , @ Ckd+$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$ !T!Ckd$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$T!`!!!!!!!Ckd'$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$!!!!""""@"N"P"X"\"f"h"z""""""""####&#j#l#r#t#########$$ $$ $.$0$8$<$F$H$R$$$$$$$$$$$$$ %%%%*%8%:%B%F%P%R%^%%%hAdCJPJhAdB*CJPJphhAdB*CJPJphhAdB*CJPJo(ph hAdCJ hAdCJo(M!""@"P"Z"\"h"Ckd3$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$h"|"""""##Ckd?$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$##(#l#t#### $d$Ifa$####$$ $0$OCCCCCC $d$Ifa$kdK$$IfT4֞ 'v'c-^4|r344 laf4T0$:$<$H$T$$$$CkdW$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$$$$$$$%%Ckdc $$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$%*%:%D%F%R%`%%Ckdo!$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$%%%%%%%%%%%%%&&&(&4&6&>&@&B&p&~&&&&&&&&&&&6'8'F'H'P'T'^'`'v'''((^(h(j(r(v(((())&)()))))))))**(***P*^*`*h*l*¼¼¼¼¼ hAdCJ hAdCJo(hAdB*CJPJo(phhAdB*CJPJphhAdB*CJPJphhAdCJPJo(hAdCJPJJ%%%%%%%&Ckd{"$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$&(&B&p&&&&&Ckd#$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$&&&&8'H'R'T'Ckd$$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$T'`'x''(^(j(t( $d$Ifa$t(v((()()))OCCCCCC $d$Ifa$kd%$$IfT4֞ 'v'c-^4|r344 laf4T)))))***P*Ckd&$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$P*`*j*l*x***$+Ckd'$$IfT4֞ 'v'c-^4|r344 laf4T $d$Ifa$l*v*x******++ ++++++++"+$+4+6+@+B+P+R+Z+^+h+j+z++++++++++++++,,,,(,*,<,,,----t...ݩݩѩѩݗݩݩݩhAdB*CJPJ\phhAdhAdB*CJPJo(phhAdCJPJo(hAdCJH*PJhAdCJPJhAdB*CJPJphhAdB*CJPJphhAdCJPJo( hAdCJ hAdCJo(;$+B+R+\+^+j+|++Ckd($$IfT4p֞ 'v'c-^4|r344 laf4T $d$Ifa$++,,,,*,>,Ckd)$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$>,,,--d.f.t.Ckdy*$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$t....////Ckd#+$$IfT4[֞ 'v'c-^4r344 laf4T $d$Ifa$....///////0\0^0f0h00000000011 11l1n1v1x111111 22$2h2r2t2222222223^3f3h3p3r33333ҺúҺ޺޺hAdB*CJPJaJph&hAdB*CJOJPJQJ^Jo(phhAdCJPJo(hAdCJOJPJQJ^Jo(hAdB*CJPJphhAdCJPJhAdB*CJPJphhAdB*CJPJo(ph ֞ 'v'c-^4r344 laf4T $d$Ifa$3l4|44442545B5D5X55556"$8:<pr*,8:LN"0<HJ\6BDV UhAdB*CJPJphhAdB*CJPJo(phhAdCJPJhAdCJPJo(hAdB*CJPJphN4445D55555Ckd.$$IfT4,֞ 'v'c-^4r344 laf4T $d$Ifa$ic Gel/Akten3.5%1ml:0.035g Akorn Inc/Thea Pharma Inc.*gۏSSxoTXR N^Sc gNThea Pharma Inc.27-46%tYN~ }|Erythromycin Ethylsuccinate Granules/E.E.S.Eryped200mg/5mlArbor Pharmaceuticals LLC/AZURITY PHARMACEUTICALS INC*gۏSSxoTXR N^Sc gNAZURITY PHARMACEUTICALS INC27-47%tYN~ }|Erythromycin Ethylsuccinate Granules/E.E.S.Eryped400mg/5mlArbor Pharmaceuticals LLC*gۏSSxoTXR N^Sc gNAZURITY PHARMACEUTICALS INC23-192vxyrkUBRTerbinafine Hydrochloride Spray /Lamisil1%(15ml0.15g)Glaxosmithkline Consumer HealthcareUK Trading Limited/ GlaxoSmithKline Consumer Healthcare GmbH & Co. KG/ Haleon UK Trading Limited*gۏSSxoTXRSfT N^Sc gNHaleon UK Trading Limited23-193vxyrkUBRTerbinafine Hydrochloride Spray /Lamisil1%(30ml0.3g)glaxosmithkline Consumer HealthcareUK Trading Limited/ GlaxoSmithKline Consumer Healthcare GmbH & Co. KG/ Haleon UK Trading Limited*gۏSSxoTXRSfT N^Sc gNHaleon UK Trading Limited48-53n^UsNKetoconazole Cream/Nizoral 2% Creme2%Johnson & Johnson GmbH/STADA Consumer Health Deutschland GmbH*gۏSSxoTXR N^Sc gNSTADA Consumer Health Deutschland GmbH27-45x2u0WU[nGrMegestrol Acetate Tablets40mgPar Pharmaceutical Inc/Strides Pharma Science LimitedVElQv TyoTXRSfT N^Sc gNStrides Pharma Science Limited27-515vxn]eS gnmBromhexine Hydrochloride Oral Solution/Bisolvon4mg/5mlSanofi/Opella Healthcare/ Opella Healthcare Italy S.r.l.*gۏSSxoTXR N^Sc gNHealthcare Italy S.r.l.29-97u2q\hl\mMannitol-S Injection/00000003l\m300mle,g}2X*h_O>y/*h_O>y}2X*gۏSSxoTXRSfT N^Sc gN:N*h_O>y}2X31-55[lx/lle@ll\mClemastine Fumarate Injection /Tavegil2ml2mgN/lle@l Glaxosmithkline Consumer Healthcare GmbH & Co. KG/Gebro Pharma GmbH*gۏSSxoTXRSfTv N^Sc gNGebro Pharma GmbH10-133nfW^GrProbucol Tablets/Lorelco0.25g(250mg)Otsuka Pharmaceutical Co., Ltd./'YZX*h_O>y*gۏSSxoTXRSfT N^Sc gN:N'YZX*h_O>y0ĉy*gۏSSxoTXRSf N^Sc gN000000*h_O>y39-43g|jxfW^nGrTandospirone Citrate Tablets5mg'Ye,gOOS*h_O>y/OOS0000*h_O>y*gۏSSxoTXRSfTv N^Sc gNOOS0000*h_O>y51-44g|jxfW^nGrTandospirone Citrate Tablets/Sediel10mg'Ye,gOOS*h_O>y/OOS0000*h_O>y*gۏSSxoTXRSfTv N^Sc gNOOS0000*h_O>y10-71NW0W"l{VGrCandesartan Cilexetil and Hydrochlorothiazide Tablets/ NP[FUT TkGr+TNW0WlfWo8mg "l/l{VU12.5mg8Takeda GmbH/CHEPLAPHARM Arzneimittel GmbH /AstraZenece*gۏSSxNT'kv N^ NP[FUT T10-72NW0W"l{VGrCandesartan Cilexetil and Hydrochlorothiazide Tablets/ NP[FUT TkGr+TNW0WlfWo16mg "l/l{VU12.5mgTakeda GmbH/CHEPLAPHARM Arzneimittel GmbH /AstraZenece*gۏSSxNT'kv N^ NP[FUT T43-9lfN/lSl\mFamotidine and Sodium Chloride Injection / Famotidine Injection0.4mg/mlBaxter Healthcare CorprationVElQv TyoTfee T:NFamotidine Injection26-126Rwx?yyrWS8TeQ(unmArformoterol Tartrate Inhalation Solution/BrovanaEQ 0.015mg BASE/2mlSunovion Pharmaceuticals Inc/Lupin Inc*gۏSSxoTXRSfTv N^Sc gNLupin Inc22-34?zTUHel\BR/l\(u?zTUAripiprazole Powder and Solvent for Prolonged-release Suspension for Injection300mgOtsuka Pharmaceutical Co., Ltd.*gۏSSxoTfe(u T:Nl\(u?zTU22-35?zTUHel\BR/l\(u?zTUAripiprazole Powder and Solvent for Prolonged-release Suspension for Injection400mgOtsuka Pharmaceutical Co., Ltd.*gۏSSxoTfe(u T:Nl\(u?zTU67-29xx"l@nnbcm4mmol/Le Hemofiltration Replacement Fluid of Sodium Bicarbonate4mmol/L Potassium Calcium free /PrismaSol5000ml250ml/4750ml BAXTER HEALTHCARE CORP*gۏSSxoTfe(u T:Nxx"l@nnbcm4mmol/Le 29-12vx.lSSe@lne\'`oir N TNnfSf[oir wQ gN[vyrk'`Y>e\'`0eHe'`0 c>e\'`;m^~oI{yrp Sk6RBR;N(uNfnxvQxSvhTW,gBl S9hncvQoiryr'` Te~TSk6RBRvS_'`ۏLxvz0       PAGE 2    PAGE \* MERGEFORMAT1   5<rCkd;/$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$:NCkd/$$IfT4e֞ 'v'c-^4r344 laf4T $d$Ifa$"2: $d$Ifa$:<J^OCCCCCC $d$Ifa$kd0$$IfT4d֞ 'v'c-^4r344 laf4T46DXCkd91$$IfT44 ֞ 'v'c-^4r344 laf4T $d$Ifa$:D 2HZ\t6D*V`blnxzJPRXhPZ :<Vfh|޳޳hAdCJPJo(&hAdB*CJOJPJQJ^Jo(phhAdB*CJPJo(phhAdCJPJhAdB*CJPJphhAdB*CJPJo(phF,.:FCkd1$$IfT4 ֞ 'v'c-^4r344 laf4T $d$Ifa$ Ckd2$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$H\Ckd73$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$6F Ckd3$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$,nzCkd4$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$Jj@ $d$Ifa$@BP\ OCCCCCC $d$Ifa$kd55$$IfT4֞ 'v'c-^4r344 laf4T HJV~Ckd5$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$|<L8>@jln|~ LN\^ "28Bnz|(*@Nb0BDP ݻݻhAdB*CJPJo(ph&hAdB*CJOJPJQJ^Jo(phhAdB*CJPJo(phhAdCJPJhAdB*CJPJphJ<NCkd6$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$N8Ckd37$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$8@n~Ckd7$$IfT4>֞ 'v'c-^4r344 laf4T $d$Ifa$ N^Ckd8$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$"RCkd19$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$|*B $d$Ifa$BDNd0DOCCCCCC $d$Ifa$kd9$$IfT4֞ 'v'c-^4r344 laf4TDz| 4Ckd:$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$ 2 02@B,:<VZf|<>`bz|~Z\jl*.8DxhAdCJPJo(hAdB*CJPJ\phhAdB*CJPJo(phhAdB*CJPJphhAdCJPJNCkd/;$$IfT4a֞ 'v'c-^4r344 laf4T $d$Ifa$ BCkd;$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$,<XZfCkd<$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$T~Ckd-=$$IfT4 ֞ 'v'c-^4r344 laf4T $d$Ifa$\l,.Ckd=$$IfT4֞ 'v'c-^4r344 laf4T $d$Ifa$.8F"l $d$Ifa$ "<nz,.<"46@B\fr`btv8BL\^",.hAdCJPJhAdB*CJPJ\phhAdB*CJPJphhAdB*CJPJo(phQlnz OCCCCCC $d$Ifa$kd>$$IfT4֞ 'v'c-^4r344 laf4TFPCkd+?$$IfT4v֞ 'v'c-^4r344 laf4T $d$Ifa$"$.>Ckd?$$IfT4u֞ 'v'c-^4r344 laf4T $d$Ifa$"6Ckd@$$IfT4l ֞ 'v'c-^4r344 laf4T $d$Ifa$Ckd)A$$IfT4D ֞ 'v'c-^4r344 laf4T $d$Ifa$T`dfrCkdA$$IfT4 ֞ 'v'c-^4r344 laf4T $d$Ifa$rbvCkd}B$$IfT4 ֞ 'v'c-^4r344 laf4T $d$Ifa$D^ $d$Ifa$ ".B$OCCCCCC $d$Ifa$kd'C$$IfT4֞ 'v'c-^4r344 laf4T.@B"$.BDZ^j| bhNT  $&*,꬧hAd0JB*CJaJo(phhAdjhAdU hAdo(/jhAdB*CJOJPJQJ UaJo(phhAdB*CJPJo(phhAdB*CJKHPJo(phhAdCJPJhAdB*CJPJphhAdCJPJo(3$\^j~CkdC$$IfT4v֞ 'v'c-^4r344 laf4T $d$Ifa$dC55 $d$G$Ifa$kd{D$$IfT4u ֞ 'v'c-^4r344 laf4T $d$Ifa$P "$(*|zzzzzzzz $da$gdQ"kkd%E$$IfT4c0^4 44 laf4pT $d$Ifa$ ,02>@BDJLPRX\^ǻǃ~ hAdo(hAdB*CJaJo(phjhAdCJUaJ*&hhCJaJmHnHsHu*hAdCJaJjhAdCJUaJhAdCJaJo(jhAdUhAdhAd0JCJaJjhAd0JCJUaJhAd0JCJaJo(*LNPTVX $da$gdQ"$4$a$h]h&`#$ ? 00182P0:pQ"A .!"#$%Sn $$If!vh#v{#v#v{ #vO#vZ #v#v:V 44,55r555355/ /  / af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4S,55r555355/ / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4T,5|5r555355/ / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4.,5|5r555355/ / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4p,5|5r555355/ / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4.,5|5r555355/ / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4f,5|5r555355/ / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 47,5|5r555355/ / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4y,5|5r555355/ / / / / / / / af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4S,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4.,5|5r555355/ / / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4f,5|5r555355/ / / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / /  af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,5|5r555355/ / / / / / / / af4T $$If!vh#v{#v#v{ #vO#vZ #v#v:V 4p,5|5r555355/ / / / / / / / af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4[,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4?,55r555355/ /  / af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4> ,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4e,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4d,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 44 ,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4 ,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4>,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4a,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4 ,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4v,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4u,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4l ,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4D ,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4 ,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4 ,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4v,55r555355/ af4T$$If!vh#v{#v#v{ #vO#vZ #v#v:V 4u ,55r555355/ af4T$$If!vh#v{#vO0:V 4c ,55/ /  / af4pT s  8 66 666668 0@P`p6888 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ OJ PJQJ _HmH nHsH tHR`R cke $1$a$(CJKHOJQJ_HaJmH nHsH tH$A $ ؞k=W[SONi@N nfh-\".B-?7}>FTlon77Ԝx?|+NST2 XiEꭶ?j]m^_^+P[wD+PW-W_YW ͶW5 R ~,VAFXuVKsKTCV]rŦZ-t  ;b6#42% qv8›q. B˟TDFLڐAB&~ ^] ُ=q==~NV;(VG:=ՃxiJ!x?>~?< }a\G5TLx?y;~nьHbwc:EGP~Ds |w<4rg!Rt|+c m߆6Il!Q] sZ;aQITjYV`<$6D='Ienb~k3MHýS^P\wr^+j~k~vt~t«(:zQk_۶sWb/?ѹS)uzݜnrʵ+Am~޽: 5ˁWrbJAүsUTjzf5η1T>汀*^PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!.theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] - #-P """%~  !%l*.3| ., &-3>FNV[anL R  *,r~v T!!h"##0$$%%&&T't()P*$++>,t./012t345:@ N8BD.lr $*!"#$%'()*+,./012456789:;<=?@ABCDEGHIJKLMOPQRSTUWXYZ\]^_`bz{|}~%!#!@ @ (    T(( e,gFh 1c"? PKPK N@drs/PKN@Ωydrs/downrev.xmlM1k0B@FN83tKZ bH'#)s-v9w߫wbĘ@ VRLOs "eMF@`֕ 7:x̝JV`s*)Sk {,c'M7NEzzrzg!cm?mVi*6 2Nf:+$.&{dy]dSPKN@drs/e2oDoc.xmlS͎0#iU -<؍%6 ps0v\g<3fo&rw ].*Jo_ެ)]ˍwg fզ\ΛVF >4K)ԌA: *-OxF#5lUUoYc1H'@rJF( OH :nKJI>+2PdʉEm7>D:-sZxrj'ǨZD^D"bY=A.(5rK$Mqq;Yfy5fK;?̬m"q|WhZ+ aC^zKЈ+GHc꜒9A?ǁrcJ~|z|C9%C]FlCԇ,Q[0Nqbݴ]y%K PK N@_rels/PKN@f< _rels/.relsj0 }qN/k؊c[F2e~"Kl`0;1 (6{PF783.#c(Y ̵W͘tT0Dlm#]ڀzgͿ0n .):&viUe6F,jY~}_G>~WoPKN@~ [Content_Types].xmlAN0EH%N@%邴K@`dOdlyLhoDX3'AL:*/@X*eRp208J妾)G,R}Q)=HiҺ0BL):T뢸WQDY;d]6O&8* VCLj"󃒝 yJ.;[wIC_ :{IOA !>Ø4 Swl9rj̛Mt֎k8풺toPKN@~  F[Content_Types].xmlPK N@(_rels/PKN@f<  L_rels/.relsPK N@drs/PKN@Ωy 8drs/downrev.xmlPKN@ 4drs/e2oDoc.xmlPKYn T(  B  c 4()1vcޏc&{ 63"&?PKPK N@drs/PKN@=qdrs/downrev.xmlMON0#"qvZQ@\"qK4v=C3zq1vk& &η6DL o0//*,M8֩clJC)el,90g#ñf#^N;,hZ|Z{1}f[bU@$:?3su6콉g2qgI+\lWn #'jj\FF ׼WEp漴l]0i 0Ţ,BN7O@׶Jȍ{#mQ#_nVmQFkNLc^ٻT]+1ej>kL8SD"b^>}^f.$5`60|əC~ǯO_~~7L" +0oCb|lIŽYYXyLeY(Isq+$t%Z*8H(>$kň4-z +۰x򤏥gSF6iI(YU/ڦgt"DeM5'Iy9yhrܦa{'[]PK N@_rels/PKN@f< _rels/.relsj0 }qN/k؊c[F2e~"Kl`0;1 (6{PF783.#c(Y ̵W͘tT0Dlm#]ڀzgͿ0n .):&viUe6F,jY~}_G>~WoPKN@~ [Content_Types].xmlAN0EH%N@%邴K@`dOdlyLhoDX3'AL:*/@X*eRp208J妾)G,R}Q)=HiҺ0BL):T뢸WQDY;d]6O&8* VCLj"󃒝 yJ.;[wIC_ :{IOA !>Ø4 Swl9rj̛Mt֎k8풺toPKN@~  }[Content_Types].xmlPK N@__rels/PKN@f<  _rels/.relsPK N@drs/PKN@=q 8drs/downrev.xmlPKN@"f <drs/e2oDoc.xmlPKYB S  ? --8o(8t%@ @ pAdQ"*O ]--@---- -  "$&(*.4Unknown G.[x Times New Roman5Symbol3. .[x Arial;= |8ўSOSimHei7E eck\h[{SO;5 N[_GB2312?|8I{~DengXian1. P<*_oŖў;([SOSimSun-= |8N[7..{$ CalibriA$BCambria Math QhGG&R&R!ir-r-JQP) $P*O2! xx guilpc Oh+'0T    (4<DLguil Normal.dotmpc2Microsoft Office Word@@*)@*)& ՜.+,D՜.+, X`lt| Rr- (S[wKSOProductBuildVerICV2052-11.8.2.11929$193492C76DC334B62FEA70661632B9B3  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry F)Data E1Table1WordDocumentAPSummaryInformation(DocumentSummaryInformation8CompObjn  FMicrosoft Word 97-2003 ĵ MSWordDocWord.Document.89q